01640mam a2200325 a 4500011338848MiAaHDL20110215000000.0m d cr bn ---auaua980306s1998 dcua b f000 0 eng d0160561035sdr-pur997353997353AEX9835PU(OCoLC)38559602GPOGPOn-us---1016-B (MF)1016-AY 4.G 74/7:B 62/5Serial no. 105-70 (United States. Congress. House. Committee on Government Reform and Oversight)United States.Congress.House.Committee on Government Reform and Oversight.Subcommittee on Human Resources.FDA oversight :blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.Washington :U.S. G.P.O. :For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,1998.iii, 427 p. :ill. ;24 cm."Serial no. 105-70."Shipping list no.: 98-0150-P.Distributed to some depository libraries in microfiche.Includes bibliographical references.Mode of access: Internet.BloodCollection and preservationSafety regulationsUnited States.Blood plasmaSafety regulationsUnited States.Plasma productsSafety regulationsUnited States.01133884820101013213020.020110215000000.020120815064345.02025-04-15T17:56:15Z2025-04-15T17:30:02ZSDR-PURUNKNOWNloader.pl-001-001BKsdr-pur997353pur1SDRPURpur1.32754067900369PUR997353PURPUR20250415googlepur1.327540679003691998pdbibUS fed doc